褪黑素对小鼠2- 细胞期胚胎发育的影响

目的:研究褪黑素对小鼠2-细胞期胚胎发育的影响。方法:在培养液中添加不同浓度褪黑素,在不同的作用时间点,观察并记录小鼠胚胎囊胚率、孵出率,研究其变化情况。结果:不同浓度褪黑素对小鼠2-细胞期胚胎存在双向作用,在10-13-10-5M之间促进细胞囊胚形成和孵出,在10-9M时促进效应达到最高,而在10-3M时则呈现出一定的毒性作用。结论:褪黑素对小鼠胚胎发育影响与褪黑素浓度密切相关。     

白细胞介素-6在急性胰腺炎中的作用及其机制研究

目的:明确白细胞介素-6(IL-6)在小鼠急性胰腺炎中的作用及其机制研究。方法:通过胰胆管结扎的方法诱导小鼠急性胰腺炎;分离小鼠胰腺腺泡细胞。采用ELISA方法检测胰腺组织或腺泡细胞裂解物中的细胞因子;通过western blot分析检测组织或细胞中IL-6或ERK表达。结果:IL-6浓度在胰腺组织和腺泡细胞中显著增加(P0.05)。在离体原代小鼠腺泡细胞,TNF-α刺激增加IL-6释放(P0.05);与此同时,IL-6刺激可增加其它促炎性细胞因子的释放,两者都涉及ERK MAP激酶通路。黄酮类化合物木犀草素抑制IL-6刺激引起白细胞介素-6(IL-6)和人巨嗜细胞激活蛋白-1(CCL2/MCP-1)释放。最后进一步证实,IL-6激活人胰腺组织中的ERK。结论:IL-6在急性胰腺炎中增加,激活炎症通路并加重急性胰腺炎。     

心钠素在GABA调节下丘脑正中隆起LHRH释放的介导作用研究

已证明脑神经递质GABA可促进下丘脑正中隆起LHRH神经元末梢的释放功能,这一作用可能通过抑制某些抑制性神经递质或调质释放而实现。本研究旨在观察作为体内循环调节肽的心钠素在大鼠脑内的分布,对LHRH释放的影响及对GABA调节LHRH释放的中介作用。实验结果发现:(1)雄性大鼠不同脑区心钠素的含量不同,其中以下丘脑正中隆起组织含量最高;(2)不同浓度的心钠素(10~(-8)-10~(-6)mol/L)可显著抑制LHRH从下丘脑正中隆起释放,并呈现剂量反应关系。(3)GABA(10~(-6)mol/L组)可显著抑制心钠素的释放;GABA的这一抑制作用可被GABA受体拮抗剂荷包牡丹碱(Bicuculline)完全反转。上述结果提示心钠素参与调节下丘脑正中隆起(ME)LHRH神经元末梢的释放机能,它亦可能介导GABA对下丘脑正中隆起LHRH的调节作用。     

褪黑素对小鼠2-细胞期胚胎发育的影响

目的：研究褪黑素对小鼠2-细胞期胚胎发育的影响。方法：在培养液中添加不同浓度褪黑素,在不同的作用时间点,观察并记录小鼠胚胎囊胚率、孵出率,研究其变化情况。结果：不同浓度褪黑素对小鼠2-细胞期胚胎存在双向作用,在10-13-10-5M之间促进细胞囊胚形成和孵出,在10-9M时促进效应达到最高,而在10-3M时则呈现出一定的毒性作用。结论：褪黑素对小鼠胚胎发育影响与褪黑素浓度密切相关。     

2-12烷基-6-甲氧基环己基-2,5-二烯-1,4-二酮(DMDD)抗弥漫大B淋巴瘤的作用及机制*

目的:探讨2-12烷基-6-甲氧基环己基-2,5-二烯-1,4-二酮(DMDD)抗弥漫大B淋巴瘤(DLBCL)的作用及分子机制。方法:动物实验取4周龄BALB/C小鼠,分5组,20只/组,腹股沟注射DLBCL细胞株OCI-LY19细胞1 × 10⁷ cells/ml 每只0.1 ml,两天后分别灌胃0、1、5、25、125 mg/kg剂量的DMDD,1次/2天,给药的第18日,杀10只小鼠,取瘤组织称重,记录剩余小鼠的生存期。细胞实验取OCI-LY19细胞加入96孔培养板,每孔100 μl 1×10⁵ cells/ml,分别加入100 μl DMDD使其终浓度分别为0、1、5、25和125 μmol/L,作用0、24、48和72 h,设三复孔,MTS法检测细胞增殖活性;根据细胞增殖实验结果,选择0 μmol/L、5 μmol/L和25 μmol/L的DMDD作为后续用药浓度作用OCI-LY19细胞24 h,流式细胞仪分析凋亡率,hoechst染色观察细胞核型,JC-1染色观察线粒体膜电位,LDH释放实验评估药物细胞毒性,qPCR、Western blot分析基因转录和表达水平。结果:动物实验表明:与0 mg/kg用药组比,1～125 mg/kg DMDD能抑制小鼠瘤组织生长并延长其生存期(P＜0.01)。细胞实验表明:DMDD用药组OCI-LY19细胞增殖活性明显降低、凋亡水平显著增加(P＜0.01),细胞核出现碎裂、凝集和凋亡小体及线粒体膜电位下降,LDH释放率显著增加(P＜0.01),细胞内caspase-3和bax基因的转录表达和IκBα的磷酸化水平显著上调,bcl-2、bcl-xL、jak2和stat3基因的转录和蛋白表达水平明显受抑(P＜0.01)。结论:DMDD通过抑制JAK2/STAT3和NF-κB信号通路中JAK2、STAT3和p-IκBα的表达,下调BCL-2/BAX、活化Caspase-3,最终激活OCI-LY19细胞线粒体凋亡的内源性通路而促进了DLBCL细胞凋亡,抑制了OCI-LY19细胞增殖,具有抗DLBCL的作用。     

刺参糖胺聚糖抗仙台病毒作用机制的探讨

目的:探讨刺参糖胺聚糖的抗仙台病毒(Sendaivirus,SV)作用及其作用机制.方法:选用不同浓度刺参糖胺聚糖作用于仙台病毒感染BHK21细胞的多个环节,倒置显微镜观察病毒致细胞痛变效应,MTT法检测细胞活性;同时以SV滴鼻感染小鼠,观察刺参糖胺聚糖对感染病毒小鼠血凝抑制抗体产生的影响.结果:刺参糖胺聚糖浓度大于3.2mg/ml时表现出细胞毒性作用.浓度在0.25～0.2mg/ml范围时,刺参糖胺聚糖作用病毒吸附组和病毒复制组能明显抑制细胞病变,MTT结果也表明该两组显示较好的细胞活性,且具有一定的量效关系,无细胞毒性作用;但SJ-GAG直接作用病毒组、预处理细胞组以及抑制病毒穿入组无明显抗病毒作用.动物实验表明刺参糖胺聚糖可促进小鼠血凝抑制抗体的产生.结论:刺参糖胺聚糖的抗仙台病毒作用主要通过抑制病毒对靶细胞的吸附以及抑制病毒复制而实现,并能促进小鼠对病毒感染的免疫应答.     

氯化钴对小鼠NIH3T3细胞增殖和凋亡的影响

目的:观察氯化钴(Cocl2)对体外培养的小鼠NIH3T3细胞增殖和凋亡的影响.方法:首先利用MTT法和流式细胞术检测不同浓度Cocl2对小鼠NIH3T3细胞增殖及凋亡的影响.然后利用免疫印迹检测HIF-1α和凋亡相关蛋白Bcl-2及Bax的表达.结果:(1)MTT结果显示,低于250μ mol/L的Cocl2作用NIH3T3细胞24 h对细胞的增殖活力影响不大,当浓度增加到500μ mol/L以上时会明显抑制细胞的增殖活力.(2)流式细胞仪检测结果显示低浓度Cocl2(≤ 250μ mol/L)并不会引起NIH3T3细胞明显的凋亡和坏死,增加浓度(≥500μmol/L)会导致细胞早期凋亡和坏死增加.3)不同浓度Cocl2作用NIH3T3细胞24 h均可诱导细胞中HIF-1α表达上调,同时Bax/Bcl-2的比值增高.结论:高浓度Cocl2可以抑制小鼠NIH3T3细胞增殖,促进凋亡发生.     

槲皮素抑制中枢神经突触前兴奋性依赖的胞吞动力学（英文）

目的 槲皮素是一种广泛分布于药用植物中的黄酮类化合物，传统被认为具有神经保护作用。本研究利用位于大鼠脑干花萼状突触的突触前神经末梢进行膜片钳记录，研究槲皮素调控突触传递和可塑性的突触前机制。方法 利用全细胞膜片钳结合膜电容记录，在突触后记录微小兴奋性突触后电流（m EPSC），在突触前神经末梢记录钙內流和神经囊泡的释放、回收以及可立即释放库（RRP）的恢复动力学。并且利用纤维刺激在轴突给予5～200 Hz的刺激，诱发突触后EPSC，记录突触后短时程抑制（STD）。结果 100μmol/L槲皮素不影响突触后m EPSC的振幅、频率以及AMPA受体的动力学特征。在突触前神经末梢，槲皮素不改变钙内流或囊泡的释放，但显著抑制胞吐后网格蛋白依赖的慢速胞吞。抑制胞吞会导致突触前囊泡动员的减慢，降低RRP的补充速率，并且增强高频刺激下的短时程可塑性STD。结论 本研究为槲皮素调控中枢神经突触传递提供全新的突触前神经机制，槲皮素有助于抑制中枢神经过度兴奋，进而发挥神经保护作用。     

不同浓度降钙素基因相关肽对小鼠海马区长时程增强的影响

本研究旨在探讨不同浓度的降钙素基因相关肽(calcitonin gene-related peptide,CGRP)对小鼠海马长时程增强的影响。将30日龄C57BL/6J小鼠随机分为空白组、不同浓度(50,100,200 nmol/L)CGRP组,CGRP+CGRP阻断剂组,每组10只。外源性给予海马区脑片不同浓度的CGRP,用离体细胞外场电位记录检测其对小鼠海马突触传递及长时程增强的影响。结果显示,给予不同浓度CGRP对小鼠海马突触前递质的释放没有明显的影响,但100和200 nmol/L CGRP可易化海马长时程增强的诱发,表现为长时程增强幅度的增加,并且这一作用可被CGRP特异性阻断剂CGRP8-37阻断。以上结果提示,CGRP可通过特异性受体浓度依赖性促进小鼠海马长时程增强的诱发。     

葡萄糖对小鼠胚胎体外发育的影响

通过在CZB培养液中添加不同浓度葡萄糖及在胚胎发育的不同阶段加入葡萄糖,对小鼠胚胎进行体外培养,以探讨葡萄糖在小鼠早期胚胎体外发育中的作用。其结果表明,小鼠胚胎在含糖CZB与在无糖CZB中培养比较,4-细胞发育率无差异;各浓度葡萄糖组囊胚率显著高于无糖组,其中3.0mmol/L浓度组囊胚细胞数显著高于其余组;实验二：2-细胞至4-细胞、4-细胞至桑椹胚前添加葡萄糖囊胚率显著提高。上述结果证明,在小鼠胚胎体外培养中加入葡萄糖不会导致2-细胞阻滞;葡萄糖浓度增加至10mmol/L对小鼠胚胎无毒性作用,其最适浓度为3.0mmol/L;2-细胞至4-细胞、4-细胞至桑椹胚前添加葡萄糖是必要的。关键词 葡萄糖;小鼠;2-细胞阻滞;胚胎;体外发育     

Opposing functions of two sub‐domains of the SNARE‐complex in neurotransmission

The SNARE‐complex consisting of synaptobrevin‐2/VAMP‐2, SNAP‐25 and syntaxin‐1 is essential for evoked neurotransmission and also involved in spontaneous release. Here, we used cultured autaptic hippocampal neurons from Snap‐25 null mice rescued with mutants challenging the C‐terminal, N‐terminal and middle domains of the SNARE‐bundle to dissect out the involvement of these domains in neurotransmission. We report that the stabilities of two different sub‐domains of the SNARE‐bundle have opposing functions in setting the probability for both spontaneous and evoked neurotransmission. Destabilizing the C‐terminal end of the SNARE‐bundle abolishes spontaneous neurotransmitter release and reduces evoked release probability, indicating that the C‐terminal end promotes both modes of release. In contrast, destabilizing the middle or deleting the N‐terminal end of the SNARE‐bundle increases both spontaneous and evoked release probabilities. In both cases, spontaneous release was affected more than evoked neurotransmission. In addition, the N‐terminal deletion delays vesicle priming after a high‐frequency train. We propose that the stability of N‐terminal two‐thirds of the SNARE‐bundle has a function for vesicle priming and limiting spontaneous release.     

Halothane Increases Non-vesicular [<Superscript>3</Superscript>H]dopamine Release from Brain Cortical Slices

Experimental data suggest that halothane anesthesia is associated with significant changes in dopamine (DA) concentration in some brain regions but the mechanism of this effect is not well known. Rat brain cortical slices were labeled with [³H]DA to further characterize the effects of halothane on the release of this neurotransmitter from the central nervous system. Halothane induced an increase on the release of [³H]DA that was dependent on incubation time and anesthetic concentration (0.012, 0.024, 0.048, 0.072 and 0.096 mM). This effect was independent of extracellular or intracellular calcium. In addition, [³H]DA release evoked by halothane was not affected by TTX (blocker of voltage-dependent Na⁺ channels) or reserpine (a blocker of vesicular monoamine transporter). These data suggest that [³H]DA release induced by halothane is non-vesicular and would be mediated by the dopamine transporter (DAT) and norepinephrine transporter (NET). GBR 12909 and nomifensine, inhibitors of DAT, decreased the release of [³H]DA evoked by halothane. Nisoxetine, a blocker of NET, reduced the release of [³H]DA induced by halothane. In addition, GBR 12909, nisoxetine and, halothane decrease the uptake of [³H]DA into rat brain cortical slices. A decrease on halothane-induced release of [³H]DA was also observed when the brain cortical slices were incubated at low temperature and low extracellular sodium, which are known to interfere with the carrier-mediated release of the neurotransmitter. Ouabain, a Na⁺/K⁺ ATPase pump inhibitor, which induces DA release through reverse transport, decreased [³H]DA release induced by halothane. It is suggested that halothane increases [³H]DA release in brain cortical slices that is mediated by DAT and NET present in the plasma membrane.     

Effect of endothelin-1 on the excitability of rat cortical and hippocampal slices in vitro

Endothelin-1 (ET-1) is a neuroactive protein produced in most brain cell types and participates in regulation of cerebral blood flow and blood pressure. In addition to its vascular effects, ET-1 affects synaptic and nonsynaptic neuronal and glial functions. Direct application of ET-1 to the hippocampus of immature rats results in cerebral ischemia, acute seizures, and epileptogenesis. Here, we investigated whether ET-1 itself modifies the excitability of hippocampal and cortical circuitry and whether acute seizures observed in vivo are due to nonvascular actions of ET-1. We used acute hippocampal and cortical slices that were preincubated with ET-1 (20 μM) for electrophysiological recordings. None of the slices preincubated with ET-1 exhibited spontaneous epileptic activity. The slope of the stimulus intensity-evoked response (input-output) curve and shape of the evoked response did not differ between ET-1-pretreated and control groups, suggesting no changes in excitability after ET-1 treatment. The threshold for eliciting an evoked response was not significantly increased in either hippocampal or cortical regions when pretreated with ET-1. Our data suggest that acute seizures after intrahippocampal application of ET-1 in rats are likely caused by ischemia rather than by a direct action of ET-1 on brain tissue.     

Reactive oxygen species induced by presynaptic glutamate receptor activation is involved in [H]GABA release from rat brain cortical nerve terminals

We investigated the production of reactive oxygen species (ROS) as a response to presynaptic glutamate receptor activation, and the role of ROS in neurotransmitter (GABA) release. Experiments were performed with rat brain cortical synaptosomes using glutamate, NMDA and kainate as agonists of glutamate receptors. ROS production was evaluated with the fluorogenic compound dichlorodihydrofluorescein diacetate (H₂DCF-DA), and GABA release was studied using synaptosomes loaded with [³H]GABA. All agonists were found to stimulate ROS production, and specific antagonists of NMDA and kainate/AMPA receptors, dizocilpine hydrogen maleate (MK-801) and 6-cyano-7-nitroquinoxaline-2,3-done (CNQX), significantly inhibited the ROS increase. Spontaneous as well as agonist-evoked ROS production was effectively attenuated by diphenyleneiodonium (DPI), a commonly used potent inhibitor of NADPH oxidase activity, that suggests a high contribution of NADPH-oxidase to this process. The replacement of glucose with pyruvate or the simultaneous presence of both substrates in the medium led to the decrease in spontaneous and NMDA-evoked ROS production, but to the increase in ROS production induced by kainate. Scavenging of agonist-evoked ROS production by a potent antioxidant N-acetylcysteine was tightly correlated with the inhibition of agonist-evoked GABA release. Together, these findings show that the activation of presynaptic glutamate receptors induces an increase in ROS production, and there is a tight correlation between ROS production and GABA secretion. The pivotal role of kainate/AMPA receptors in ROS production is under discussion.     

Phorbol Ester Enhancement of Neurotransmitter Release from Rat Brain Synaptosomes

Neurotransmitter release from rat brain synaptosomes was measured following pretreatment with various phorbol esters. Ca2+-dependent, evoked neurotransmitter release was increased by phorbol esters that were active in stimulating protein kinase C. Protein kinase C activation was demonstrated by increased incorporation of 32P into 87-kilodalton phosphoprotein, a specific substrate for that kinase. Inactive phorbol esters had no effect on neurotransmitter release or on the phosphorylation of 87-kilodalton phosphoprotein. The increased release was observed in either crude cortical synaptosomal fractions (P2) or purified cortical synaptosomal fractions. The enhancement was found for all neurotransmitters (norepinephrine, acetylcholine, gamma-aminobutyric acid, serotonin, dopamine, and aspartate), all brain regions (cerebral cortex, hippocampus, and corpus striatum), and all secretagogues (elevated extracellular K+ level, veratridine, or A23187) examined. It was also observed at all calcium concentrations present during stimulation of release. The phorbol ester enhancement of Ca2+-dependent release occurred whether or not calcium was present during pretreatment. These results indicate that stimulation of protein kinase C leads to an enhanced sensitivity of the stimulus-secretion coupling processes to calcium within the nerve terminal. The results support the possibility that presynaptic activation of protein kinase C modulates nerve terminal neurotransmitter release in the CNS.     

Early network activity propagates bidirectionally between hippocampus and cortex

Spontaneous activity in the developing brain helps refine neuronal connections before the arrival of sensory‐driven neuronal activity. In mouse neocortex during the first postnatal week, waves of spontaneous activity originating from pacemaker regions in the septal nucleus and piriform cortex propagate through the neocortex. Using high‐speed Ca²⁺ imaging to resolve the spatiotemporal dynamics of wave propagation in parasagittal mouse brain slices, we show that the hippocampus can act as an additional source of neocortical waves. Some waves that originate in the hippocampus remain restricted to that structure, while others pause at the hippocampus‐neocortex boundary and then propagate into the neocortex. Blocking GABAergic neurotransmission decreases the likelihood of wave propagation into neocortex, whereas blocking glutamatergic neurotransmission eliminates spontaneous and evoked hippocampal waves. A subset of hippocampal and cortical waves trigger Ca²⁺ waves in astrocytic networks after a brief delay. Hippocampal waves accompanied by Ca²⁺ elevation in astrocytes are more likely to propagate into the neocortex. Finally, we show that two structures in our preparation that initiate waves—the hippocampus and the piriform cortex—can be electrically stimulated to initiate propagating waves at lower thresholds than the neocortex, indicating that the intrinsic circuit properties of those regions are responsible for their pacemaker function. © 2015 Wiley Periodicals, Inc. Develop Neurobiol 76: 661–672, 2016     

Depolarization-Induced Superoxide Radical Formation in Rat Hippocampal Slices

Glutamate is the major excitatory neurotransmitter in the brain. Activation of glutamatergic receptors induces neuronal depolarization, and if this activation is excessive, it can lead to cellular damage. Evidence for the participation of glutamatergic receptor systems in the production of oxygen free radicals in neuronal cells is accumulating. In the present study, we have kept hippocampal slices under depolarization conditions induced by including 50 mM K⁺ in artificial cerebrospinal fluid (dACSF) and followed superoxide radical formation. Superoxide radical formation was increased in dACSF-incubated hippocampal slices. We have also attempted to determine the relative contribution of agonist- and voltage-sensitive channels to superoxide radical formation by using their selective blockers. Superoxide radical formation was suppressed by MK 801, memantine, APV, CNQX, and TTX application to dACSF-incubated hippocampal slices. Similar studies on different experimental systems may help to unravel the underlying critical events and active mechanisms that may lead to superoxide radical generation and subsequent neuronal cell death.     

Effect of Latrotoxin-Like Protein on Spontaneous Postsynaptic Activity in Hippocampal Cell Cultures

-Latrotoxin, an active component of black widow spider venom, is known to enhance spontaneous neurotransmitter release. In cultured rat hippocampal neurons, we studied the effects of latrotoxin-like protein (protein purified from the bovine brain and exhibiting some functional properties similar to those of -latrotoxin) on spontaneous GABA-ergic inhibitory currents (IPSC). Latrotoxin-like protein was found to dramatically increase the frequency of spontaneous IPSC recorded in cell cultures of dissociated hippocampal neurons in the presence of tetrodotoxin. Possible mechanisms of the action of latrotoxin-like protein on transmitter release are discussed.     

Inhibition by Cyclic AMP of Phorbol Ester-Potentiated Norepinephrine Release from Guinea Pig Brain Cortical Synaptosomes

The involvement of Ca2+/phospholipid-dependent protein kinase (protein kinase C, PKC) and cyclic AMP-dependent protein kinase in the K+-evoked release of norepinephrine (NE) was studied using guinea pig brain cortical synaptosomes preloaded with [3H]NE. 12-O-Tetradecanoylphorbol-13-acetate (TPA), a potent activator of PKC, enhanced the K+-evoked release of [3H]NE, in a concentration-dependent manner, but with no effect on the spontaneous outflow and uptake of [3H]NE in the synaptosomes. The apparent affinity of the evoked release for added calcium but not the maximally evoked release was increased by TPA (10(-7) M). Inhibitors of PKC, polymyxin B, and a more potent inhibitor, staurosporine, counteracted the TPA-induced potentiation of the evoked release. Both forskolin and dibutyryl cyclic AMP (DBcAMP) enhanced the evoked release, but reduced the TPA-potentiated NE release. A novel inhibitor of cyclic AMP-dependent protein kinase, KT5720, blocked both the forskolin-induced increase in the evoked release and its inhibition of TPA-induced potentiation in the evoked release, thereby suggesting that forskolin or DBcAMP counteracts the Ca2+-dependent release of NE by activating cyclic AMP-dependent protein kinase. These results suggest that the activation of PKC potentiates the evoked release of NE and that the activation of cyclic AMP-dependent protein kinase acts negatively on the PKC-activated exocytotic neurotransmitter release process in brain synaptosomes of the guinea pig.     

Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons

AimsThe FDA approved smoking cessation aid varenicline can effectively attenuate nicotine-stimulated dopamine release. Varenicline may also exert important actions on other transmitter systems that also influence nicotine reinforcement or contribute to the drug's cognitive and affective side effects. In this study, we determined if varenicline, like nicotine, can stimulate presynaptic GABA release.Main methodsUsing whole-cell patch-clamp techniques, we measured GABA_AR-mediated asynchronous, spontaneous miniature inhibitory postsynaptic currents (mIPSCs) in acute brain slices from two brain regions important for learning and memory, the hippocampus and basal forebrain.Key findingsBoth varenicline (10 μM) and nicotine (10 μM) applications alone resulted in small but significant increases in amplitude, as well as robustly enhanced frequency of mIPSCs in hippocampal CA1 pyramidal neurons and medial septum/diagonal band (MS/DB) neurons. A unique subpopulation of MS/DB neurons showed decreases in frequency. In the presence of nicotine, varenicline effectively attenuated the expected enhancement of hippocampal mIPSC frequency like a competitive antagonist. However, in the MS/DB, varenicline only partially attenuated nicotine's effects. Reversing the order of drug application by adding nicotine to varenicline-exposed slices had little effect.SignificanceVarenicline, like nicotine, stimulates presynaptic GABA release, and also exerts a partial agonist action by attenuating nicotine-stimulated release in both the hippocampus and basal forebrain. These effects could potentially affect cognitive functions.